
### [NCIT:C3730](http://purl.obolibrary.org/obo/NCIT_C3730)
**Label:** Mixed Mesodermal (Mullerian) Tumor

**Subclasses:** [NCIT:C6336](http://purl.obolibrary.org/obo/NCIT_C6336) (Uterine Corpus Adenosarcoma), [NCIT:C6338](http://purl.obolibrary.org/obo/NCIT_C6338) (Uterine Corpus Adenomyoma), [NCIT:C6337](http://purl.obolibrary.org/obo/NCIT_C6337) (Uterine Corpus Adenofibroma), [NCIT:C40229](http://purl.obolibrary.org/obo/NCIT_C40229) (Cervical Adenosarcoma), [NCIT:C40029](http://purl.obolibrary.org/obo/NCIT_C40029) (Borderline Ovarian Serous Cystadenofibroma), [NCIT:C40028](http://purl.obolibrary.org/obo/NCIT_C40028) (Borderline Ovarian Serous Adenofibroma), [NCIT:C40069](http://purl.obolibrary.org/obo/NCIT_C40069) (Borderline Ovarian Endometrioid Adenofibroma), [NCIT:C27289](http://purl.obolibrary.org/obo/NCIT_C27289) (Borderline Ovarian Endometrioid Cystadenofibroma), [NCIT:C27288](http://purl.obolibrary.org/obo/NCIT_C27288) (Ovarian Endometrioid Cystadenofibroma), [NCIT:C27287](http://purl.obolibrary.org/obo/NCIT_C27287) (Ovarian Endometrioid Adenofibroma), [NCIT:C7317](http://purl.obolibrary.org/obo/NCIT_C7317) (Ovarian Adenosarcoma), [NCIT:C9180](http://purl.obolibrary.org/obo/NCIT_C9180) (Uterine Corpus Carcinosarcoma), [NCIT:C113239](http://purl.obolibrary.org/obo/NCIT_C113239) (Uterine Carcinosarcoma, Heterologous Type), [NCIT:C67092](http://purl.obolibrary.org/obo/NCIT_C67092) (Ovarian Serous Adenocarcinofibroma), [NCIT:C8979](http://purl.obolibrary.org/obo/NCIT_C8979) (Mucinous Cystadenofibroma), [NCIT:C67090](http://purl.obolibrary.org/obo/NCIT_C67090) (Serous Adenofibroma), [NCIT:C113238](http://purl.obolibrary.org/obo/NCIT_C113238) (Uterine Carcinosarcoma, Homologous Type), [NCIT:C8978](http://purl.obolibrary.org/obo/NCIT_C8978) (Mucinous Adenofibroma), [NCIT:C8975](http://purl.obolibrary.org/obo/NCIT_C8975) (Malignant Mixed Mesodermal (Mullerian) Tumor), [NCIT:C42700](http://purl.obolibrary.org/obo/NCIT_C42700) (Uterine Carcinosarcoma), [NCIT:C40124](http://purl.obolibrary.org/obo/NCIT_C40124) (Fallopian Tube Carcinosarcoma), [NCIT:C40125](http://purl.obolibrary.org/obo/NCIT_C40125) (Fallopian Tube Adenosarcoma), [NCIT:C9192](http://purl.obolibrary.org/obo/NCIT_C9192) (Ovarian Carcinosarcoma), [NCIT:C40085](http://purl.obolibrary.org/obo/NCIT_C40085) (Ovarian Clear Cell Adenofibroma), [NCIT:C40041](http://purl.obolibrary.org/obo/NCIT_C40041) (Ovarian Mucinous Cystadenofibroma), [NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma), [NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma), [NCIT:C40040](http://purl.obolibrary.org/obo/NCIT_C40040) (Ovarian Mucinous Adenofibroma), [NCIT:C40081](http://purl.obolibrary.org/obo/NCIT_C40081) (Borderline Ovarian Clear Cell Adenofibroma), [NCIT:C102570](http://purl.obolibrary.org/obo/NCIT_C102570) (Uterine Ligament Adenosarcoma), [NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma), [NCIT:C3726](http://purl.obolibrary.org/obo/NCIT_C3726) (Adenomyoma), [NCIT:C8988](http://purl.obolibrary.org/obo/NCIT_C8988) (Clear Cell Cystadenofibroma), [NCIT:C8986](http://purl.obolibrary.org/obo/NCIT_C8986) (Papillary Adenofibroma), [NCIT:C8987](http://purl.obolibrary.org/obo/NCIT_C8987) (Clear Cell Adenofibroma), [NCIT:C8984](http://purl.obolibrary.org/obo/NCIT_C8984) (Female Reproductive System Adenofibroma), [NCIT:C8985](http://purl.obolibrary.org/obo/NCIT_C8985) (Cystadenofibroma), [NCIT:C9474](http://purl.obolibrary.org/obo/NCIT_C9474) (Adenosarcoma), [NCIT:C40113](http://purl.obolibrary.org/obo/NCIT_C40113) (Fallopian Tube Serous Adenofibroma), [NCIT:C40114](http://purl.obolibrary.org/obo/NCIT_C40114) (Fallopian Tube Serous Cystadenofibroma), [NCIT:C36097](http://purl.obolibrary.org/obo/NCIT_C36097) (Cervical Carcinosarcoma), [NCIT:C40034](http://purl.obolibrary.org/obo/NCIT_C40034) (Ovarian Mucinous Adenocarcinofibroma), [NCIT:C40035](http://purl.obolibrary.org/obo/NCIT_C40035) (Adenocarcinofibroma), [NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma), [NCIT:C40230](http://purl.obolibrary.org/obo/NCIT_C40230) (Cervical Adenofibroma), [NCIT:C126478](http://purl.obolibrary.org/obo/NCIT_C126478) (Broad Ligament Serous Adenofibroma), [NCIT:C40032](http://purl.obolibrary.org/obo/NCIT_C40032) (Ovarian Serous Cystadenofibroma), [NCIT:C40231](http://purl.obolibrary.org/obo/NCIT_C40231) (Cervical Adenomyoma), [NCIT:C126477](http://purl.obolibrary.org/obo/NCIT_C126477) (Broad Ligament Serous Cystadenofibroma), [NCIT:C40031](http://purl.obolibrary.org/obo/NCIT_C40031) (Ovarian Serous Adenofibroma), [NCIT:C126311](http://purl.obolibrary.org/obo/NCIT_C126311) (Ovarian Seromucinous Adenofibroma), 

**Class expressions from DL-Learner:**

- [UBERON:0000474](http://purl.obolibrary.org/obo/UBERON_0000474) (female reproductive system) 60.00%
- [NCIT:C61611](http://purl.obolibrary.org/obo/NCIT_C61611) (Tissue of Mullerian Origin Present) 60.00%
- [NCIT:C35907](http://purl.obolibrary.org/obo/NCIT_C35907) (Biphasic Pattern) 60.00%
- Thing 51.45%
- [UBERON:0000990](http://purl.obolibrary.org/obo/UBERON_0000990) (reproductive system) 38.87%
- [NCIT:C37150](http://purl.obolibrary.org/obo/NCIT_C37150) (Neoplastic Stromal Cell) 30.41%
- [NCIT:C35867](http://purl.obolibrary.org/obo/NCIT_C35867) (Morphologic Finding) 23.63%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 23.51%
- [NCIT:C83490](http://purl.obolibrary.org/obo/NCIT_C83490) (Microscopic Finding) 23.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 23.34%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 22.52%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 21.92%
- [NCIT:C42075](http://purl.obolibrary.org/obo/NCIT_C42075) (Abnormal Tissue Present) 16.93%
- [NCIT:C35886](http://purl.obolibrary.org/obo/NCIT_C35886) (Morphologic Architectural Pattern) 16.20%
- [NCIT:C36887](http://purl.obolibrary.org/obo/NCIT_C36887) (Neoplastic Connective and Soft Tissue Cell) 15.59%


